CD4+ T cell anergy in transplantation tolerance requires continuous Treg-dependent control of IL-2 availability
Donor-specific transplantation tolerance promises to free recipients from complications associated with lifelong immunosuppression. Anergy, a CD4 + conventional T cell (Tconv)-intrinsic state of long-term hypofunction, is thought to arise when T cells encounter cognate antigen in the absence of costimulation. Anti-CD154 (αCD154), an antibody that blocks T cell costimulation and is currently in clinical trials, can induce donor-specific transplantation tolerance in mice in association with anergy of Tconvs recognizing persistently expressed alloantigens. Using murine models of fully mismatched cardiac allograft tolerance or repeated alloantigen exposure, we demonstrate that αCD154 is not sufficient and regulatory T cells (Tregs) are necessary to induce and sustain αCD154-mediated alloreactive Tconv anergy. Transient depletion of Tregs disrupted the induction of αCD154-mediated Tconv anergy, and in mice with established tolerance, Treg depletion transcriptionally and functionally reinvigorated previously anergic Tconvs. Mechanistically, Treg depletion increased IL-2 availability and IL-2R signaling in Tconvs, and exogenous IL-2 could bypass Treg-mediated control to partially restore Tconv function. Thus, the state of αCD154-mediated Tconv anergy is less cell-intrinsic than previously thought and requires Tregs to limit IL-2 availability for both its induction and its continuous enforcement. Selecting immunosuppressive drugs that preserve this Treg function may be critical for achieving stable clinical transplantation tolerance.
Authors
- Michael S. Andrade (ORCID: https://orcid.org/0000-0002-1404-3015)
- Ricardo Mora-Cartín (ORCID: https://orcid.org/0000-0001-9994-9715)
- Montserrat Kwan (ORCID: https://orcid.org/0000-0001-5202-0140)
- Domenic Abbondanza (ORCID: https://orcid.org/0000-0002-7202-0225)
- Jennifer Allocco (ORCID: https://orcid.org/0000-0002-1498-0543)
- Christine M. Mcintosh (ORCID: https://orcid.org/0000-0003-3401-8914)
- Anita S. Chong (ORCID: https://orcid.org/0000-0003-0460-0196)
- Alexandra Cassano (ORCID: https://orcid.org/0000-0003-3144-8716)
- Peter Wang (ORCID: https://orcid.org/0000-0001-7790-2596)
- Ying Wang
- Maria L. Alegre
- Shuang Wu
- Ephraim Craddock
Institutions
- University of Chicago (US)
Publication Details
- Journal
- Journal of Clinical Investigation
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1172/jci206638
- Primary Topic
- T-cell and B-cell Immunology
- Type
- article
- Field-Weighted Citation Impact
- 0.00